Skip to content
Journal

Journal of Pharmaceutical Research International

Published by SCIENCEDOMAIN international · ISSN (electronic) 2456-9119

Search within this journal

7,450

Articles indexed

84

2026 articles

7,450

Open access

23,663

Citations (indexed)

Publications by year

Articles (7450)

Evaluation of Catalase and Manganese in Type 2 Diabetic Patients in University of Port Harcourt Teaching Hospital

Arvin Nwakulite, Emmanuel I. Obeagu, Richard Eze, C. C. N. Vincent, Ejike Felix Chukwurah, Chukwuma J. Okafor, Adaobi Maryann Ibekwe, Calista Ndidi Adike, Ufuoma Chukwuani & Bart I. Ifionu · Journal of Pharmaceutical Research International · 2021

This study was carried out to evaluate catalase and manganese in type 2 diabetes mellitus patients. A total of 40 subjects Were included in this study. This comprised of equal number of male and female subjects respectively. Enzyme linked immunosorbent assay (ELISA) method was us...

Open access Research Article 10.9734/jpri/2021/v33i30B31638

A comparative Clinical Study to Evaluate the Efficacy of Anuvasan Basti with Brahatchaglyadi Ghritam and Guggulutiktam Ghritam in the management of Gridhrasi (Sciatica): A Study Protocol

Arun Kumar Gupta, Shweta Parwe, Trupti Gupta & Milind Nisargandha · Journal of Pharmaceutical Research International · 2021

Background: Gridhrasi is such a Ruja Pradhaana Vatavyadhi. In Gridhrasi intense shooting pain characteristically radiates from Sphika (gluteal region) to Pada (foot). Based on symptoms of Gridhrasi, it can be equated with the disease sciatica in modern science. The lifetime incid...

Open access Research Article 10.9734/jpri/2021/v33i30A31623

Comparative Assessment of Kukkutanda Pinda Sweda and Patra Pinda Sweda in the Management of Manyastambha (Cervical Spondylosis) - A Study Protocol

Vivek Kumar Verma, Shweta Parwe & Milind Nisargandha · Journal of Pharmaceutical Research International · 2021

Background: At the present time, human beings are easily prone to get several degenerative disorders because of their stressful and reckless lifestyle. 'Manyastambha' is one such lifestyle disorder instigated from excessive use of vehicle, excessive travelling, continuous sitting...

Open access Research Article 10.9734/jpri/2021/v33i30A31624

A Comparative Study to Evaluate the Efficacy of Lekhana Basti and Modified Vachadi Gana Basti in Combination with Navaka Guggulu in Sthaulya (Obesity) -A Study Protocol

Amiya Bhonsle, Shweta Parwe & Milind Nisargandha · Journal of Pharmaceutical Research International · 2021

Background: Sthoulya described as Obesity occurs due to the vitiation of Kapha & Vata. The signs and symptoms of Sthoulya can be correlated with Obesity. This has been said in Ayurveda and Sthaulya purusha (Obese person) is considered one of the nindita Purusha. Lekhaniya gan...

Open access Research Article 10.9734/jpri/2021/v33i30A31626

Protocol on Comparative Clinical Efficacy of Tryushanadi Guggul and Navaka Guggul in Sthoulya (Overweight)

Ashvini Dineshrao Pardhekar, Sadhana Misar(Wajpeyi) & Vinod Ade · Journal of Pharmaceutical Research International · 2021

Background: Sthoulya is Medovaha Strotodushtijanya vyadhi, which includes abnormal and excessive accumulation of Medodhatu in the body. This is caused by lack of physical and mental activity, daytime sleep, excessive intake of madhur (sweet), snigdha ahar (oily diet) results in ...

Open access Research Article 10.9734/jpri/2021/v33i30A31628

Research Protocol for Assessment of Solitary and Combined effect of Guduchi and Punarnava on Structural and Functional Changes of Ageing in Liver and Kidney in Wistar Rats

Kalpana Tawalare, Pradnya Dandekar, Priti Desai & Kiran Tawalare · Journal of Pharmaceutical Research International · 2021

Background: The liver and kidney play a central role in metabolic and detoxification processes leads to structural degeneration of organs with aging, which may hamper the functional ability of these organs. Acharya charaka suggests to use drugs of vayasthapana mahakashaya in diff...

Open access Research Article 10.9734/jpri/2021/v33i30A31630

Androgenetic Alopecia as a Marker of Metabolic Syndrome

Faryal Hussain Memon, Abdul Ghani Rahimoon, Pardeep Kumar, Shahid Hussain Memon, Erum Siddiqui, Tarachand Devrajani, Samar Raza & Syed Zulfiquar Ali Shah · Journal of Pharmaceutical Research International · 2021

Background: Alopecia induced by androgens in genetically predisposed individuals is termed as Androgenetic alopecia (AGA). There is proof appearance the relationship between Androgenetic alopecia and metabolic condition. Objective: To determine frequency of metabolic syndrome in...

Open access Research Article 10.9734/jpri/2021/v33i30A31625

Hepatoprotective Activity of Acampe praemorsa

Praveen Kumar Uppala, G. S. N. Koteswara Rao, A. Rajasekhar Reddy, K. Umasankar, C. Joshitha, Kanagala Anusha, Nadeem Siddiqui & Sarada Prasanna Mallick · Journal of Pharmaceutical Research International · 2021

Introduction: Liver is one of major functional organ in body, its damage can alter body metabolisms and other organs’ function. So, it is very important to maintain the healthy liver. Now a days, different chemicals and inadequate use of medicines are causing liver impairments in...

Open access Research Article 10.9734/jpri/2021/v33i30A31627

Development and Validation of Direct Spectrophotometric Method for the Estimation of Glimepiride

Dilip Chafle & Lata Awale · Journal of Pharmaceutical Research International · 2021

Aims: To develop simple, sensitive and direct spectrophotometric methods for the estimation of widely prescribed antidiabetic hypoglycemic agent Glimepiride in pure and pharmaceutical dosage form. Place and duration of study: Research Centre of Taywade Group of Institution Koradi...

Open access Research Article 10.9734/jpri/2021/v33i30A31629

Development and Validation of New Analytical LC-MS/MS Method for the Estimation of Antidiabetic Drugs Ertugliflozin and Sitagliptin in Combined Pharmaceutical Dosage form

Suleman S. Khoja & Laxman J. Patel · Journal of Pharmaceutical Research International · 2021

Ertugliflozin and Sitagliptin is combination of Antidiabetic drug in tablet Steglujan 15 mg/100 mg film-coated tablets®, a member Antidiabetic drug, is a recent drug developed by Merck Sharp and Dohme Company for the treatment of Type 2 diabetes. Ertugliflozin and Sitagliptin can...

Open access Research Article 10.9734/jpri/2021/v33i30A31631